WHX Dubai — Dubai, 25–28 Jan 2027
Direct answer
The organiser states a 4,200-exhibitor scale for 2027 and publishes partner and pavilion evidence. A complete reusable edition directory has not yet passed the Horizon check. The organiser offers ticket, stand and Connections Programme routes; current prices and eligibility must be checked at booking. Separate provider, distributor, procurement, investor and government target groups before selecting access Use the two-venue zone map to build category-specific days rather than a generic exhibition walk
- Editorial author
- Horizon Strategies
- Last verified in the editorial record
- Scope
- UAE · Healthcare & Life Sciences
| Fact or procedure | Recorded evidence | Authority and source | Checked |
|---|---|---|---|
| Recorded dates | 25–28 Jan 2027 | Original source | 2026-10-28 |
| Recorded city | Dubai | Original source | 2026-10-28 |
| Participation evidence | The organiser offers ticket, stand and Connections Programme routes; current prices and eligibility must be checked at booking. | Original source | 2026-10-28 |
Limits and what this does not prove: The 90,000+ professional, 4,200+ exhibitor, 195-country and 235,000-visit figures are organiser projections, not a complete named attendee or buyer list. The public partner and pavilion evidence does not establish the complete 2027 exhibitor roster or procurement authority of attending organisations. Ticket, conference, Connections Programme and invitation-only entitlements differ; registration alone does not guarantee access to a target programme or meeting. Medical products and digital-health services still require product, clinical, data, distributor and regulatory checks outside the event process.
Event evidence
The organiser states a 4,200-exhibitor scale for 2027 and publishes partner and pavilion evidence. A complete reusable edition directory has not yet passed the Horizon check.
The organiser offers ticket, stand and Connections Programme routes; current prices and eligibility must be checked at booking.
Separate provider, distributor, procurement, investor and government target groups before selecting access
Use the two-venue zone map to build category-specific days rather than a generic exhibition walk
Test medical-device, diagnostics, digital-health or service propositions against named buying and regulatory routes
Questions before commitment
Which clinical, procurement or operating outcome must the offer improve?
Which target organisations and roles belong at each venue and programme?
Which product registration, distributor, data or clinical-evidence gate must be cleared before follow-up?